2021
DOI: 10.1186/s12948-021-00162-9
|View full text |Cite
|
Sign up to set email alerts
|

Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis

Abstract: To fight against coronavirus disease 2019 (COVID-19), the vaccination is currently the most effective approach. However, in addition to common systemic side effects, the vaccines can cause serious allergic reactions or anaphylaxis. In anaphylaxis, the exposure to the allergen causes a sudden release of chemical mediators from mast cells, for which adrenaline is the drug of first choice. In our previous basic studies, in addition to adrenaline, anti-allergic drugs (olopatadine, loratadine, tranilast and ketotif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…3 Adrenaline also inhibits further mast cell degranulation, preventing additional deterioration. 4 Intramuscular adrenaline autoinjectors are prescribed for the immediate management and stabilisation of out-of-hospital anaphylaxis while medical attention is sought. Per Australian guidelines, such autoinjectors are recommended for patients with a clinical history of anaphylaxis, coexisting food allergy and unstable asthma or mast cell disorders, and are typically sold by the brand names EpiPen or Anapen.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…3 Adrenaline also inhibits further mast cell degranulation, preventing additional deterioration. 4 Intramuscular adrenaline autoinjectors are prescribed for the immediate management and stabilisation of out-of-hospital anaphylaxis while medical attention is sought. Per Australian guidelines, such autoinjectors are recommended for patients with a clinical history of anaphylaxis, coexisting food allergy and unstable asthma or mast cell disorders, and are typically sold by the brand names EpiPen or Anapen.…”
mentioning
confidence: 99%
“…Intramuscular adrenaline is the first‐line treatment for severe anaphylaxis because of its actions of peripheral vasoconstriction, decreased vascular permeability and bronchodilation, which act to prevent mortality from distributive shock or asphyxiation 3 . Adrenaline also inhibits further mast cell degranulation, preventing additional deterioration 4 . Intramuscular adrenaline autoinjectors are prescribed for the immediate management and stabilisation of out‐of‐hospital anaphylaxis while medical attention is sought.…”
mentioning
confidence: 99%